Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
CVS, Barclays and Medicare
CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst
Barclays upgraded CVS Health Inc (NYSE:CVS) on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by share gains, with further upside potential from CostVantage. Despite macroeconomic pressures impacting the retail pharmacy sector,
CVS Health upgraded at Barclays on Medicare prospects
CVS Health (CVS) stock gained as Barclays upgraded the company, citing a compelling path to margin recovery in its Medicare Advantage business. Read more here.
Why CVS Health stock could appreciate 35% from here
Discover why TD Cowen sees 35% upside in CVS Health stock, driven by Medicare Advantage improvements and bullish technical signals.
Why CVS Health Won’t Break Off Aetna From Its Medical Providers
Talk that CVS Health may break up its businesses would mean unraveling synergies already making the company a lot of money.
CVS Stock Rises on Upgrade. Why Barclays Sees a ‘Compelling’ Opportunity.
Analysts upgraded shares of the healthcare company to Overweight from Equal Weight and raised their price target to $82.
Barclays ups CVS Health to Buy on positive margin outlook; shares rise
Barclays upgraded CVS Health Corp (NYSE:CVS) shares to Overweight from Equal Weight, citing a promising outlook for the company's margin recovery. The firm also raised its price target for CVS shares to $82 from $63.
6h
on MSN
Humana Has a Problem. CVS and UnitedHealth Could Pick Up the Pieces.
Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...
Fierce Healthcare
4h
Medicare Advantage star ratings 2025—Who are the winners and losers?
Analyses of 2025 Medicare Advantage star ratings continue to pour in and not all of it bodes well for the conventional ...
5d
on MSN
CVS is under pressure and considering a breakup. Here's why that could be risky.
CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health ...
Modern Healthcare
1d
Oak Street Health expansion to continue amid CVS review
CVS is reportedly conducting a strategic review and weighing options for separating some of the company’s businesses.
Healthcare Dive
8h
Medicare Advantage star ratings fall again in 2025
About 40% of MA plans with prescription drug coverage will earn four or more stars, a dip from 42% this year, according to data released by the CMS.
In Depth
10d
on MSN
In Depth
Exclusive: CVS explores options including potential break-up, sources say
CVS Health is exploring options that could include a break-up of the company to separate its retail and insurance units, as ...
Yahoo
15h
Copycat weight loss drugs, Amazon's pharmacies, and CVS vs. Lina Khan: Pharma news round up
Read More Allowing
Medicare
to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending ...
8h
CMS reveals new 2025 Medicare plan ratings
Medicare Advantage plans are changing their quality ratings, with the Centers for Medicare & Medicaid Services (CMS) ...
10d
on MSN
Health insurers unveil Medicare Advantage plans for 2025
CVS Health and Cigna on Tuesday released details on their government-backed health insurance plans for next year for people ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Humana
Barclays
UnitedHealth Group
Feedback